PH iWell Study to Compare an Online Interactive Technology to Self-directed Care in Overweight or Obese Individuals
SKTA iWell21 Clinical Trial Protocol. This is a Randomized Control Trial of 500 Adult Participants Randomized to Two Arms: Control Arm: Self Directed Program (SDP), Intervention Arm: Dynamic On-line Interactive Technology (DOIT)
1 other identifier
interventional
500
1 country
1
Brief Summary
This is a six month lifestyle management study to compare the effects of iWell; a dynamic online interactive technology to a self-directed program in overweight or obese individuals. The primary aim is to test the hypothesis that dynamic online interactive technology intervention is more effective than self-directed program in obtaining and maintaining weight loss and other biometric improvements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2010
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2010
CompletedFirst Submitted
Initial submission to the registry
October 22, 2010
CompletedFirst Posted
Study publicly available on registry
March 29, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2012
CompletedApril 19, 2011
April 1, 2011
1 year
October 22, 2010
April 17, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Weight loss from baseline
at 6 months
Secondary Outcomes (8)
Blood pressure change from baseline
at 3 months
Triglyceride level change from baseline
at 3 months
High density lipoprotein level change from baseline
at 3 months
Physical activity adjustment from baseline
at 3 months
Blood pressure change from baseline
at 6 months
- +3 more secondary outcomes
Study Arms (2)
Self directed
NO INTERVENTIONTechnology assisted health behavior
ACTIVE COMPARATORThe intervention arm will have access to a dynamic online environment with social networking and device data uploads that include activity data, weight data and laboratory data at frequent intervals to nudge optimal health behavior.
Interventions
Web-based interactive program using an hpod sensor that tracks physical activity as well as biometric parameters into the iWell server and is transmitted to the internet site via the users PC. Also serves as a social networking site.
Receives support and encouragement with minimal contact. Receives printed lifestyle guidelines with diet and physical activity recommendations.
Eligibility Criteria
You may qualify if:
- age 18-70 years old
- overweight or obese men and women with BMI between 24 and 38, inclusive
- concerned about weight/health (and motivated in losing weight)
- stable medications for past 3 months
- willing/able to use Web-based services
- willingness not to use weight loss medications for the duration of the trial
- able and willing to give informed consent and participate in the interventions
- willing to come to three sessions and visits
- willingness to be randomized to intervention or control group
You may not qualify if:
- contraindication to weight loss (e.g., malignancy or other serious illness)
- Type 1 DM and Type 2 DM with other end organ compromise (renal, retinal or other)
- Recent (within 6 months) cardiovascular event (MI or stroke)
- current symptoms of angina
- heart, renal, or liver disease (excluding kidney stone)
- cancer or active neoplasm (excluding skin cancers)
- hyperthyroidism
- mental conditions that would preclude full participation
- prior weight-loss (bariatric) surgery or plan for these procedures
- liposuction surgery in past 12 months or plan for these procedures
- recent weight loss in the past 3 months (\>20 lbs)
- use of prescription weight loss medication in 3 months prior to screening
- current use of medications for treatment of psychosis or manic-depressive illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- SK Telecom Americas, Inc.lead
- PeaceHealth Laboratoriescollaborator
Study Sites (1)
PeaceHealth Laboratories
Springfield, Oregon, 97477, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brigitte Piniewski, MD
PeaceHealth Laboratories
- PRINCIPAL INVESTIGATOR
David Kil
SKTelecom Americas
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
October 22, 2010
First Posted
March 29, 2011
Study Start
October 1, 2010
Primary Completion
October 1, 2011
Study Completion
October 1, 2012
Last Updated
April 19, 2011
Record last verified: 2011-04